arachidonoylserotonin and Neoplasms

arachidonoylserotonin has been researched along with Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for arachidonoylserotonin and Neoplasms

Article	Year
New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation. Journal of medicinal chemistry, 2019, 12-26, Volume: 62, Issue:24 Over the course of the past decade, peroxisome proliferator-activated receptors (PPARs) have been identified as part of the cannabinoid signaling system: both phytocannabinoids and endocannabinoids are capable of binding and activating these nuclear receptors. Fatty acid amide hydrolase (FAAH) hydrolyzes the endocannabinoid anandamide and other Topics: Amidohydrolases; Animals; Antineoplastic Agents; Humans; Neoplasms; Peroxisome Proliferator-Activated Receptors	2019

Article

Year

New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation.

Journal of medicinal chemistry, 2019, 12-26, Volume: 62, Issue:24

Over the course of the past decade, peroxisome proliferator-activated receptors (PPARs) have been identified as part of the cannabinoid signaling system: both phytocannabinoids and endocannabinoids are capable of binding and activating these nuclear receptors. Fatty acid amide hydrolase (FAAH) hydrolyzes the endocannabinoid anandamide and other

Topics: Amidohydrolases; Animals; Antineoplastic Agents; Humans; Neoplasms; Peroxisome Proliferator-Activated Receptors

2019